Close

Anixa Biosciences (ANIX) Files Pre-Submission, Requests Meeting with FDA Regarding Cchek

October 15, 2018 7:09 AM EDT Send to a Friend
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login